Editorial: quantitative [(18)F]NaF PET in metastatic and metabolic bone diseases
Name:
fnume-03-1343913.pdf
Size:
1008.Kb
Format:
PDF
Description:
Found with Open Access Button
Affiliation
Division of Cancer Sciences, The University of Manchester, The Christie NHS Foundation Trust, Manchester, United Kingdom.Issue Date
2023
Metadata
Show full item recordCitation
Puri T, Moore AE, Mahajan A, McWilliam A, Vrist MH, Blake GM. Editorial: Quantitative [(18)F]NaF PET in metastatic and metabolic bone diseases. Frontiers in nuclear medicine (Lausanne, Switzerland). 2023;3:1343913. PubMed PMID: 39355043. Pubmed Central PMCID: PMC11440861. Epub 2024/10/02. eng.Journal
Front Nuclear MedicineDOI
10.3389/fnume.2023.1343913PubMed ID
39355043Additional Links
https://dx.doi.org/10.3389/fnume.2023.1343913Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.3389/fnume.2023.1343913
Scopus Count
Collections
Related articles
- The influence of CT and dual-energy X-ray absorptiometry (DXA) bone density on quantitative [(18)F] sodium fluoride PET.
- Authors: Jassel IS, Siddique M, Frost ML, Moore AEB, Puri T, Blake GM
- Issue date: 2019 Feb
- Clinical utility of F-18 sodium fluoride PET/CT for estimating disease activity in patients with rheumatoid arthritis.
- Authors: Park HJ, Chang SH, Lee JW, Lee SM
- Issue date: 2021 Apr
- Hybrid PET- and MR-driven attenuation correction for enhanced (18)F-NaF and (18)F-FDG quantification in cardiovascular PET/MR imaging.
- Authors: Karakatsanis NA, Abgral R, Trivieri MG, Dweck MR, Robson PM, Calcagno C, Boeykens G, Senders ML, Mulder WJM, Tsoumpas C, Fayad ZA
- Issue date: 2020 Aug
- 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
- Authors: Piccardo A, Puntoni M, Morbelli S, Massollo M, Bongioanni F, Paparo F, Altrinetti V, Gonella R, Gennari A, Iacozzi M, Sambuceti G, DeCensi A
- Issue date: 2015
- A Prospective Comparison of (18)F-Sodium Fluoride PET/CT and PSMA-Targeted (18)F-DCFBC PET/CT in Metastatic Prostate Cancer.
- Authors: Harmon SA, Bergvall E, Mena E, Shih JH, Adler S, McKinney Y, Mehralivand S, Citrin DE, Couvillon A, Madan RA, Gulley JL, Mease RC, Jacobs PM, Pomper MG, Turkbey B, Choyke PL, Lindenberg ML
- Issue date: 2018 Nov